Adamas to Present at Two Upcoming Investor Conferences
Gregory T. Went, Ph.D., the company’s Founder, Chairman and Chief Executive Officer, is scheduled to present at the Deutsche Bank43rd Annual Health Care Conferenceon Tuesday, May 8, 2018at 2:50 p.m. EDT Richard A. King, the company’s Chief Operating Officer, is scheduled to present at the Bank of America Merrill Lynch2018 Health Care Conferenceon Wednesday, May 16, 2018at 1:40 p.m. PDT
The presentations will be webcast live from the investor relations section of the Adamas website at http://ir.adamaspharma.com/events-presentations. Archived versions of the webcasts will be available via replay for 30 days following the presentations.
Adamas’ goal is to create and commercialize a new generation of medicines intended to lessen the burden of chronic neurologic diseases on patients, caregivers and society using its deep understanding of time-dependent biology. The company is focused on the commercial launch of GOCOVRI™ (amantadine) extended release capsules (previously ADS-5102), the first and only
Director, Corporate Communications & Investor Relations
Continuum Health Communications
Source: Adamas Pharmaceuticals, Inc.